CNP signal peptide in patients with cardiovascular disease
J Lee, M Than, S Aldous, R Troughton… - Frontiers in …, 2015 - frontiersin.org
We have previously reported that signal peptide fragments of C-type natriuretic peptide
(CNP) are present in the human circulation. Here, we provide the first preliminary …
(CNP) are present in the human circulation. Here, we provide the first preliminary …
Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure
RK Rogers, HT May, JL Anderson, JB Muhlestein - American Heart Journal, 2009 - Elsevier
BACKGROUND: B-type natriuretic peptide (BNP) correlates with left ventricular (LV) end-
diastolic pressure (LVEDP) and predicts cardiovascular events. We sought to determine …
diastolic pressure (LVEDP) and predicts cardiovascular events. We sought to determine …
Translational phases of evidence in a prognostic biomarker: a systematic review and meta-analysis of natriuretic peptides and the prognosis of stable coronary …
S Sutaria, P Philipson, NK Fitzpatrick, K Abrams… - Heart, 2012 - heart.bmj.com
Context Translational phases of study are important in evaluating whether a prognostic
biomarker is likely to have impact on clinical practice but systematic evaluations of such …
biomarker is likely to have impact on clinical practice but systematic evaluations of such …
[HTML][HTML] Biomarkers in Acute Heart Failure–Cardiac And Kidney
AM Richards - Cardiac Failure Review, 2015 - ncbi.nlm.nih.gov
Natriuretic peptides (NP) are well-validated aids in the diagnosis of acute decompensated
heart failure (ADHF). In acute presentations, both brain natriuretic peptide (BNP) and N …
heart failure (ADHF). In acute presentations, both brain natriuretic peptide (BNP) and N …
Understanding cardiac biomarkers in end‐stage kidney disease: Frequently asked questions and the promise of clinical application
MA Roberts, AJ Hedley, FL Ierino - Nephrology, 2011 - Wiley Online Library
ABSTRACT A novel strategy in the management of cardiovascular disease in patients with
end‐stage kidney disease is the use of biochemical markers to facilitate the detection of …
end‐stage kidney disease is the use of biochemical markers to facilitate the detection of …
Equal Performance of Novel N-terminal ProBNP (Cardiac ProBNP®) and Established BNP (Triage BNP®) point-of-care tests
CG Jungbauer, B Kaess, S Buchner, C Birner… - Biomarkers in …, 2012 - Taylor & Francis
Background: Recently, a novel point-of-care test (POCT) for N-terminal proBNP (NTproBNP)
has been introduced (Cardiac proBNP®, Roche). Aim: The aim was to compare the novel …
has been introduced (Cardiac proBNP®, Roche). Aim: The aim was to compare the novel …
Increased B-type natriuretic peptide and decreased proteinuria might reflect decreased capillary leakage and is associated with a better outcome in patients with …
K de Leeuw, MK Nieuwenhuis, AS Niemeijer, H Eshuis… - Critical care, 2011 - Springer
Introduction It is difficult to adjust fluid balance adequately in patients with severe burns due
to various physical changes. B-type natriuretic peptide (BNP) is emerging as a potential …
to various physical changes. B-type natriuretic peptide (BNP) is emerging as a potential …
Natriuretic peptide guided heart failure management
AA Mohammed, JL Januzzi Jr - Current Clinical Pharmacology, 2009 - ingentaconnect.com
BNP or NT-proBNP testing has dramatically changed the management of acute heart failure
patients by aiding in early recognition, prognostication and treatment. Furthermore, recent …
patients by aiding in early recognition, prognostication and treatment. Furthermore, recent …